🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We should not only cease our negative activities, but also the motivation that gives rise to them.

Incredible work by Mark Yarmarkovich and the Maris lab - looking foward to doing this for pediatric brain tumors! nature.com/articles/s4158…

A new class of #CARTcells offers a new modality for treating solid cancers like #neuroblastoma via #immunotherapy. In @nature today, Children's Hospital’s Drs. Maris & Yarmarkovich describe how PC-CARS target cancer drivers thought to be unreachable. research.chop.edu/cornerstone-bl…

Looking forward to working with Karin Straathof💙🎗 Sergio Quezada @thisiscryc @CruzLabMimetic Kevin Litchfield Emmanuel Donnadieu Patrick J. Hanley 🧬 Mark Yarmarkovich and many others especially our amazing parent advocate team members Alice's Arc The EVAN Foundation Andrew Kaczynski

We're excited to join Dr. John Maris, Dr. Patrick Grohar, and Dr. Mark Yarmarkovich Mark Yarmarkovich along with researchers at the University College London UCL to work on pediatric solid tumor therapeutics via funding from Cancer Grand Challenges Cancer Grand Challenges! chop.edu/news/chop-rese…

Register for NY Genome Center “First Tuesday” seminar. May 2, 5-7pm with NYU Langone Health Gilad Evrony Mark Yarmarkovich Andrea Brand moderated by Benjamin Neel docs.google.com/forms/d/e/1FAI…

We’ve got a great lineup for NY Genome Center’s “First Tuesday” Cancer Seminar! Hear from NYU Langone Health's Giland Evrony (Gilad Evrony), PhD, Mark Yamarkovich (Mark Yarmarkovich), PhD & Andrea Brand (Andrea Brand), PhD this Tuesday @ 5PM. For more info & registration: bit.ly/40MVSpx

Join us tonight's for NY Genome Center's "First Tuesday" Cancer Seminar! Along with the speakers below, the event will be moderated by Benjamin G. Neel, MD, PhD (Benjamin Neel) from NYU Langone Health. Register here to attend: bit.ly/40MVSpx

Second Summer Seminar Series for our first and second year students with Mark Yarmarkovich. Thanks for an engaging talk on peptide-centric CAR-T cells driving forward innovative, highly-specific therapies for Neuroblastoma and more! 🚗

Nature research paper: Targeting of intracellular oncoproteins with peptide-centric CARs go.nature.com/472x6pr

Congrats to first-authors Yi Sun (BBCB Graduate Group), Tyler Florio, & Sagar Gupta (Penn Arts & Sciences)! This work was in collab w/ Dr. John Maris (CHOP Research), Mark Yarmarkovich (NYU Langone Health), & Myrio Tx + was funded in part by Cancer Grand Challenges, National Cancer Institute, Stand Up To Cancer, The Mark Foundation for Cancer Research, Cancer Research UK, & Asplundh Fdn

Early-stage investigators proposed #innovative high-impact research ideas for the NIH Director’s New Innovator Award. See the projects the awardees will pursue: commonfund.nih.gov/newinnovator/A… #NIHHighRisk

Congratulations to Mark Yarmarkovich (New York University School of Medicine/ CAMB Graduate Group Alumni), recipient of the @NIHDirector's New Innovator Award! Learn more about Dr. Yarmarkovich's project➡️ tinyurl.com/y37mf2ac and research interests here➡️ tinyurl.com/42jpv7f6 #NIHHighRisk NIH Common Fund

I am deeply grateful to Damon Runyon Cancer Research Foundation for supporting our new endeavors in mapping tumor-specific targets and developing new immunotherapies for cancer patients. Very excited to carry out this work and hope that this will pave the way for new options for patients!

Join us Society for Immunotherapy of Cancer Spring Scientific on #CellularTherapy for #SolidTumors in San Diego, March 12-14. Session preview: "Novel Targets for Solid Tumor Cell Therapies" featuring experts Drs. Heath Lab, Hideho Okada & Mark Yarmarkovich. Program and registration: sitcancer.org/education/spri…

Please join us in celebrating the 2025 Pershing Square Sohn Cancer Prize winners! This year’s six scientists have been selected for their bold ideas and potential to transform cancer research. The winners are: pershingsquarephilanthropies.org/news/the-persh…

We congratulate Mark Yarmarkovich, Dr. Mark Yarmarkovich of @NYUGrossman, whose lab is pioneering peptide-centric CAR T cell therapies to target essential genes driving tumor growth, developing a library of PC-CARs against various cancer drivers. vimeo.com/1085105749

Very grateful to Pershing Square Sohn Cancer Research Alliance for supporting this high impact new project! We are very excited to get this started

🎉 Excited to share in Nature Rev Immunol a Mark Yarmarkovich NYU Langone Health study that dramatically expands the known repertoire of tumour-specific peptides for #tcelltherapies. Huge thanks to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and the Preprint Club - Immunology for the cross-instituional collaboration nature.com/articles/s4157…